Tranexamic Acid and Aprotinin in Low and Intermediate-Risk Cardiac Surgery: A Non-Sponsored, Double-Blind, Randomised, Placebo-Controlled Trial
We wanted to compare the effectiveness of tranexamic acid versus aprotinin in reducing postoperative blood loss and transfusion requirements in the patient group representing the majority of cardiac surgery patients: low- and intermediate-risk patients.
1 min read
